Falcoz et al 38 also demonstrated that the sf 36 was

Info iconThis preview shows page 1. Sign up to view the full content.

View Full Document Right Arrow Icon
This is the end of the preview. Sign up to access the rest of the document.

Unformatted text preview: than the NHP in detecting changes five weeks after cardiac surgery. In contrast, Klevsgård et al [1] showed that the NHP was more responsive in patients with chronic lower limb ischaemia one month after revascularization. The result of the present study supports the TransAtlantic Inter-Society Consensus (TASC) [12] recommendation that SF-36 should be used as a generic health outcome measure in patients with chronic lower limb ischaemia. It seems to be more sensitive for detecting changes in quality of life than the NHP in patients with IC. In the group of CLI patients who have more problems with mobility and pain, however, it is harder to evaluate whether the one questionnaire is superior to the other, the NHP could be a preferable instrument in this group of patients. Conclusion The findings indicate that both the SF-36 and the NHP have acceptable degrees of reliability for group-level comparisons, convergent and construct validity one year after revascularization. Nevertheless, the SF-36 seems generally to have more superior psychometric properties and was more suitable than the NHP for evaluating quality of life in patients with intermittent claudication. The NHP, however, discriminated better among severity of ischaemia and was more responsive in detecting changes over time in patients with critical leg ischaemia. Acknowledgements This study was supported by the Helge Axon Johnson Foundation and the Department of Nursing Science, Lund University, The Vårdal Institute, The Swedish Institute for Health Sciences, Department of Surgery, Sahlgrenska University Hospital, Göteborg, Sweden. References 1. 2. 3. 4. 5. Klevsgård R, Fröberg BL, Risberg B, Hallberg IR: Nottingham Health Profile and Short Form 36 Health Survey questionnaire in patients with chronic lower limb ischaemia. Before and after revascularization. J Vasc Surg 2002, 36:310-7. Chetter IC, Spark JI, Dolan P, Scott DJA, Kester RC: Quality of life analysis in patients with chronic lower limb ischaemia: Suggestions for European standardisation. Eur J Vasc Endovasc Surg 1997, 13:597-604. Chetter IC, Dolan P, Spark JI, Scott DJA, Kester RC: Correlating clinical indicators of lower-limb ischaemia with quality of life. Cardiovasc Surg 1997, 5:361-366. Klevsgård R, Hallberg IR, Risberg B, Thomsen MB: Quality of life associated with varying degrees of chronic lower limb ischaemia: Comparison with a healthy sample. Eur J Vasc Endovasc Surg 1999, 17:319-325. Hunt SM, McEwen J, McKenna SP, Backett EM, Pope C: Subjective health of patients with peripheral vascular disease. The Practitioner 1982, 226:133-136. Page 10 of 11 (page number not for citation purposes) Health and Quality of Life Outcomes 2004, 2 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19. 20. 21. 22. 23. 24. 25. 26. 27. 28. Dormandy JA, Rutherford RB: Management of Peripheral Arterial Disease (PAD). TransAtlantic Inter-Society Consensus (TASC). Eur J Vasc Endovasc Surg 2000, 19(suppl A):1-244. Fletcher A, Gore S, Jones D, Fitzpatrick R, Spiegelhalter D, Cox D: Quality of...
View Full Document

Ask a homework question - tutors are online